UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

Increasing Cervical Cancer Screening Uptake Among Emergency Department Patients

Not Applicable

Completed

Conditions: Cervical Cancer

Interventions: Behavioral: SMS-intervention

First Posted Date: 2020-05-05

Last Posted Date: 2024-04-24

Lead Sponsor: University of Rochester

Target Recruit Count: 1116

Registration Number: NCT04374760

Locations: 🇺🇸
Nicolas Noyes Community Hospital, Dansville, New York, United States
🇺🇸
Strong Memorial Hospital Emergency Department, Rochester, New York, United States

Brain Effects of Opiate Agonist and Antagonist

Phase 4

Completed

Conditions: Chronic Low-back Pain

Interventions: Drug: Morphine

First Posted Date: 2020-04-10

Last Posted Date: 2021-05-07

Lead Sponsor: University of Rochester

Target Recruit Count: 10

Registration Number: NCT04342130

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Radiofrequency (RF) Ablation for Atrial Fibrillation (AF) in Patients With Heart Failure With Preserved Ejection Fraction

Not Applicable

Terminated

Conditions: Heart Failure With Preserved Ejection Fraction

Interventions: Procedure: RF ablation of AF using CARTO 3 and a Thermocool ST SF ablation catheter

First Posted Date: 2020-03-31

Last Posted Date: 2022-02-23

Lead Sponsor: University of Rochester

Target Recruit Count: 2

Registration Number: NCT04327596

Locations: 🇺🇸
Rochester Regional Health, Rochester, New York, United States
🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Phase 1

Active, not recruiting

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Pembrolizumab
Other: Pemetrexed (Chemotherapy)
Other: Nab-paclitaxel (Chemotherapy)

First Posted Date: 2020-03-05

Last Posted Date: 2025-01-20

Lead Sponsor: University of Rochester

Target Recruit Count: 28

Registration Number: NCT04297605

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Video-based Detection of Atrial Fibrillation

Not Applicable

Completed

Conditions: Atrial Fibrillation

Interventions: Diagnostic Test: Facial video of detection of cardiac disease

First Posted Date: 2020-02-12

Last Posted Date: 2023-01-27

Lead Sponsor: University of Rochester

Target Recruit Count: 256

Registration Number: NCT04267133

Locations: 🇺🇸
Strong Memorial Hospital, Rochester, New York, United States

Time-restricted Eating in Cancer Survivorship: A Single-arm Feasibility Pilot Study

Not Applicable

Completed

Conditions: Cancer Survivorship

Interventions: Behavioral: Time-restricted eating

First Posted Date: 2020-01-28

Last Posted Date: 2023-05-11

Lead Sponsor: University of Rochester

Target Recruit Count: 39

Registration Number: NCT04243512

Locations: 🇺🇸
Wilmot Cancer Institute, Rochester, New York, United States

Silverlon to Reduce Radiation Dermatitis

Phase 1

Completed

Conditions: Radiation Dermatitis

Interventions: Device: Silverlon

First Posted Date: 2020-01-23

Last Posted Date: 2024-01-05

Lead Sponsor: University of Rochester

Target Recruit Count: 31

Registration Number: NCT04238728

Locations: 🇺🇸
Wilmot Cancer Institute, Rochester, New York, United States

Memory and Attention Adaptation Training-Geriatrics (MAAT-G)

Not Applicable

Completed

Conditions: Cancer-related Problem/Condition
Cognitive Impairment

Interventions: Behavioral: MAAT-G

First Posted Date: 2020-01-18

Last Posted Date: 2023-11-13

Lead Sponsor: University of Rochester

Target Recruit Count: 4

Registration Number: NCT04230941

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

OptiVol for Precision Medical Management of Heart Failure

Not Applicable

Terminated

Conditions: Ischemic and Non-ischemic Cardiomyopathy

Interventions: Device: Medtronic ICD with Opti Vol-Monitor

First Posted Date: 2019-12-20

Last Posted Date: 2025-06-06

Lead Sponsor: University of Rochester

Target Recruit Count: 7

Registration Number: NCT04206501

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Risperidone for the Treatment of Huntington's Disease Involuntary Movements

Phase 2

Completed

Conditions: Huntington Disease
Chorea

Interventions: Drug: Risperidone
Device: BioStamp nPoint device

First Posted Date: 2019-12-17

Last Posted Date: 2025-03-21

Lead Sponsor: University of Rochester

Target Recruit Count: 6

Registration Number: NCT04201834

Locations: 🇺🇸
URMC Neurology; 919 Westfall Rd, Building C, Suite 100, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy